These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2268372)

  • 1. Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin.
    Henderson SJ; Lindup WE
    Biochem Pharmacol; 1990 Dec; 40(11):2543-8. PubMed ID: 2268372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of an albumin-bound furan dicarboxylic acid in patients with chronic renal failure or after a kidney transplant.
    Costigan MG; Yaqoob M; Lindup WE
    Nephrol Dial Transplant; 1996 May; 11(5):803-7. PubMed ID: 8671898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and physicochemical properties of the furan dicarboxylic acid, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia.
    Costigan MG; Gilchrist TL; Lindup WE
    J Pharm Pharmacol; 1996 Jun; 48(6):635-40. PubMed ID: 8832500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
    Henderson SJ; Lindup WE
    J Pharmacol Exp Ther; 1992 Oct; 263(1):54-60. PubMed ID: 1403803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma clearance in the rat of a furan dicarboxylic acid which accumulates in uremia.
    Costigan MG; Lindup WE
    Kidney Int; 1996 Mar; 49(3):634-8. PubMed ID: 8648903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin.
    Tsutsumi Y; Maruyama T; Takadate A; Goto M; Matsunaga H; Otagiri M
    Pharm Res; 1999 Jun; 16(6):916-23. PubMed ID: 10397614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of binding site of uremic toxins on human serum albumin.
    Sakai T; Takadate A; Otagiri M
    Biol Pharm Bull; 1995 Dec; 18(12):1755-61. PubMed ID: 8787801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?
    Costigan MG; Callaghan CA; Lindup WE
    Nephron; 1996; 73(2):169-73. PubMed ID: 8773339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
    Mabuchi H; Nakahashi H
    Ther Drug Monit; 1988; 10(3):261-4. PubMed ID: 3140432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on the plasma clearance of an albumin-bound furan dicarboxylic acid.
    Costigan MG; Yaqoob M; Lindup WE
    Nephrol Dial Transplant; 1995; 10(5):648-52. PubMed ID: 7566577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
    Oda A; Suzuki Y; Sato B; Sato H; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Sep Sci; 2022 May; 45(10):1672-1682. PubMed ID: 35247297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia.
    Mabuchi H; Nakahashi H
    Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis.
    Niwa T; Yazawa T; Kodama T; Uehara Y; Maeda K; Yamada K
    Nephron; 1990; 56(3):241-5. PubMed ID: 2077405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of protein-bound uraemic toxins on the thermodynamic characteristics of human albumin.
    Sarnatskaya VV; Lindup WE; Niwa T; Ivanov AI; Yushko LA; Tjia J; Maslenny VN; Korneeva LN; Nikolaev VG
    Biochem Pharmacol; 2002 Apr; 63(7):1287-96. PubMed ID: 11960605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.
    Tsutsumi Y; Maruyama T; Takadate A; Shimada H; Otagiri M
    Nephron; 2000 May; 85(1):60-4. PubMed ID: 10773757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding.
    Niwa T; Takeda N; Maeda K; Shibata M; Tatematsu A
    Clin Chim Acta; 1988 Apr; 173(2):127-38. PubMed ID: 3378354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced renal clearance of furancarboxylic acid, a major albumin-bound organic acid, in undialyzed uremic patients.
    Sato M; Koyama M; Miyazaki T; Niwa T
    Nephron; 1996; 74(2):419-21. PubMed ID: 8893167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of an endogenous drug-binding inhibitor present in uremic serum.
    Mabuchi H; Nakahashi H
    Nephron; 1986; 44(4):277-81. PubMed ID: 3796769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraction of uraemic toxins with activated carbon restores the functional properties of albumin.
    Sarnatskaya VV; Lindup WE; Ivanov AI; Yushko LA; Tjia J; Maslenny VN; Gurina NM; Nikolaev VG
    Nephron Physiol; 2003; 95(1):p10-8. PubMed ID: 14520007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.